IL288439A - Compounds and methods for regeneration of the thymus gland and restoration of t cells - Google Patents

Compounds and methods for regeneration of the thymus gland and restoration of t cells

Info

Publication number
IL288439A
IL288439A IL288439A IL28843921A IL288439A IL 288439 A IL288439 A IL 288439A IL 288439 A IL288439 A IL 288439A IL 28843921 A IL28843921 A IL 28843921A IL 288439 A IL288439 A IL 288439A
Authority
IL
Israel
Prior art keywords
compositions
methods
cell reconstitution
thymic regeneration
thymic
Prior art date
Application number
IL288439A
Other languages
English (en)
Hebrew (he)
Inventor
Paul William Finnegan
Daniel Joseph Nolan
Karolina Kucharova
Michael Daniel Ginsberg
Kenneth N Wills
Original Assignee
Angiocrine Bioscience Inc
Paul William Finnegan
Daniel Joseph Nolan
Karolina Kucharova
Michael Daniel Ginsberg
Kenneth N Wills
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiocrine Bioscience Inc, Paul William Finnegan, Daniel Joseph Nolan, Karolina Kucharova, Michael Daniel Ginsberg, Kenneth N Wills filed Critical Angiocrine Bioscience Inc
Publication of IL288439A publication Critical patent/IL288439A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/069Vascular Endothelial cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL288439A 2019-05-28 2021-11-25 Compounds and methods for regeneration of the thymus gland and restoration of t cells IL288439A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962853452P 2019-05-28 2019-05-28
PCT/US2020/034932 WO2020243310A1 (en) 2019-05-28 2020-05-28 Compositions and methods for thymic regeneration and t-cell reconstitution

Publications (1)

Publication Number Publication Date
IL288439A true IL288439A (en) 2022-01-01

Family

ID=73553922

Family Applications (1)

Application Number Title Priority Date Filing Date
IL288439A IL288439A (en) 2019-05-28 2021-11-25 Compounds and methods for regeneration of the thymus gland and restoration of t cells

Country Status (10)

Country Link
US (1) US20220226391A1 (https=)
EP (1) EP3976065A4 (https=)
JP (1) JP7637418B2 (https=)
KR (1) KR20220015451A (https=)
CN (1) CN114340642A (https=)
AU (1) AU2020283586A1 (https=)
CA (1) CA3141989A1 (https=)
IL (1) IL288439A (https=)
SG (1) SG11202113119QA (https=)
WO (1) WO2020243310A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2753441C2 (ru) 2016-09-13 2021-08-16 Ангиокрин Биосайенс, Инк. Гематоэнцефалический барьер, содержащий сконструированные эндотелиальные клетки
WO2024155791A1 (en) * 2023-01-18 2024-07-25 Angiocrine Bioscience, Inc. Use of umbilical vein endothelial cells for the treatment of lung injury
WO2025245461A1 (en) * 2024-05-23 2025-11-27 Thymofox Inc. Methods of activating foxn1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465732B2 (en) * 2007-01-19 2013-06-18 Cornell Research Foundation, Inc. Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
WO2016069911A1 (en) * 2014-10-29 2016-05-06 Jarrod Dudakov Use of bmp4 for thymic regeneration
RU2743761C2 (ru) 2014-12-19 2021-02-25 Анджиокрин Биосайенс, Инк. Биосовместимые имплантаты, содержащие сконструированные эндотелиальные клетки
RU2753441C2 (ru) * 2016-09-13 2021-08-16 Ангиокрин Биосайенс, Инк. Гематоэнцефалический барьер, содержащий сконструированные эндотелиальные клетки

Also Published As

Publication number Publication date
EP3976065A1 (en) 2022-04-06
JP7637418B2 (ja) 2025-02-28
US20220226391A1 (en) 2022-07-21
KR20220015451A (ko) 2022-02-08
AU2020283586A1 (en) 2021-12-23
CA3141989A1 (en) 2020-12-03
JP2022534586A (ja) 2022-08-02
SG11202113119QA (en) 2021-12-30
CN114340642A (zh) 2022-04-12
WO2020243310A1 (en) 2020-12-03
EP3976065A4 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
GB2605276B (en) Methods and compositions for genomic integration
SG11202103571XA (en) Compositions and methods for immunotherapy
IL288439A (en) Compounds and methods for regeneration of the thymus gland and restoration of t cells
IL277079B2 (en) Carnitine preparations and methods of use
SG11201912010XA (en) Pde5 compositions and methods for immunotherapy
ZA202004678B (en) Compositions comprising co-selected microbiota and methods for use thereof
EP4137033C0 (en) SYSTEM AND METHOD FOR VIEW RESTORED
GB201907733D0 (en) Methods and compositions for multiplex gene editing
IL288024A (en) Methods and preparations for the prevention of type 1 diabetes
IL291202A (en) Preparations and methods for microbiome characterization
IL290840A (en) Preparations and methods for altering cd123
SG11202112773VA (en) Rebar-equipped lumber form and construction method using rebar-equipped lumber form
IL285886A (en) Preparations and methods for the treatment of laminopathy
EP4010361A4 (en) METHODS AND COMPOSITIONS FOR RESTORING MICROGLIA
IL288830A (en) Methods for purifying an antibody and its preparations
GB201914572D0 (en) Methods and devices for secure symbiotic mining
IL285796A (en) Methods and preparations for the treatment of cancer
SG11202104675TA (en) Adenoviruses and methods for using adenoviruses
IL289915A (en) Composition and method for adoptive immunotherapy
IL291336A (en) Methods and preparations for tissue regeneration
IL286587A (en) Preparations of d-methyrosine and methods for their preparation
IL290325A (en) Biopharmaceutical preparations and related methods
ZA202107499B (en) Compounds, compositions and methods
EP3341327A4 (en) PARTICULATE HYDROXYAPATITE COMPOSITIONS AND METHODS OF PREPARATION THEREOF
HK40061713A (en) Compositions and methods for thymic regeneration and t-cell reconstitution